In Indian real estate today, the untrained eye may see a dichotomy in the massive investments pouring into the Indian residential sector and the actual on-ground demand for housing. A similar question mark was, in the past, also attached to the fact that developers kept churning out projects despite the visibly reduced uptake over the last couple of years. The fact is, there are always at least two storylines unfolding - the first and most obvious is the short-term story.
Currently, residential demand is still subdued due to the uncertainty brought on by many regulatory upheavals - all of which were necessary to make Indian real estate a better marketplace. To begin with, the Government's unexpected demonetization move late last year put a severe dampener on the resale market and also impacted the primary market to some extent. Even as the markets were recovering, RERA and GST - both of which were predicted and expected - caused considerable confusion among both developers and buyers.
Taking a good look at the short-term story on the end-user side, the state of upheaval is a result of an enforced maturing process. The turmoil this process brings with it could be compared to the growing pains one experiences during adolescence.
However, the long-term story presents a far different – and, from the point of view of institutional investors, a very compelling picture.
Much like in the stock market, the most optimal entry point for residential real estate investors is the lowest one. One does not invest when demand and prices are at their peak, but when they have 'troughed out' and when serious revival is imminent but not yet generally perceptible. Also, one does not invest when one's investments are not protected by strong laws.
In fact, residential property remained the most preferred asset class in Indian real estate during H1 2017. While overall investments in Indian realty touched $1990 million in this period, the residential sector accounted 54% ($1075 million) of total investments. In the same period, investments into commercial realty accounted for 40% ($796 million) and retail received 6% ($119 million) of total real estate investments.
What drives this trend?
Institutional investors have for long been waiting for greater transparency in the Indian real estate market, which has now arrived with the deployment of RERA and GST. While end-user sentiment is only beginning to revive now as clarity about the new regulatory changes emerges, the pent-up demand for homes is India is beyond question.
RERA will now ensure that only strong, credible developers with transparent business practices and ability to complete projects on time remain. Simultaneously, the supply pipeline has moderated - partly because non-credible players are forced to withdraw from the market, and partly because developers are being more cautious with their project launches.
All indicators point towards a decisive return of buyer interest over the next 18-24 months. Institutional investors, who are almost by definition in it for the long haul, are squarely focused on the positive signals for the future now emanating from the Indian residential property market.
Demand has never been stronger
India still has a massive shortfall of housing, and the Government is displaying serious intent on fulfilling its promise to deliver Housing for All by 2022. It has deployed several important policy-level initiatives to make housing more affordable for first-time buyers - and affordable housing a more attractive proposition for developers. RERA is effecting a major clean-up of the industry, leaving only strong and credible players in its wake, while GST has ensured a uniform and transparent taxation regime.
A large-scale revival of the residential sector, induced by rapid-fire regulatory reforms backing a massive pent-up housing demand of around 19 million homes, is now more than possible in the next 18-24 months. Unsurprisingly, institutional investors have picked this as the right time to deploy their capital into the Indian housing sector.
While affordable and mid-income housing are attracting the lion's share of investments, institutional investors are also making calculated plays into select integrated townships, which they have correctly identified as the next stage of housing evolution in a country where infrastructure development is not keeping up with housing development. Simultaneously, buyer sentiment has begun reviving on the back of rationalized property prices, reduced home loan interest rates and the fact that RERA now offers a viable level of protection to consumers.
Veterinary practices ordered to publish price lists and disclose corporate ownership under new CMA proposals.
Pet healthcare costs have risen at nearly twice the rate of inflation, investigation finds.
CVS Group shares surge 18 per cent as market welcomes lack of direct price controls on medicines.
Watchdog pushes for price transparency
Britain’s competition watchdog has provisionally ordered veterinary practices to publish price lists and disclose corporate ownership, aiming to give pet owners greater transparency in a sector where costs have risen at nearly twice the rate of inflation.
The Competition and Markets Authority (CMA) said on Wednesday (15) that pet owners are often unaware of prices or not given estimates for treatments that can run into thousands of pounds.
Under the proposed measures, vet businesses must publish prices for common procedures and make clear which practices are independent and which belong to large corporate chains. The watchdog also plans to cap prescription fees and ban bonuses linked to specific treatments.
“We believe that the measures we are proposing would be beneficial to the sector as a whole, including vets and vet nurses,” the CMA stated in its provisional decision report. “Providing better information for pet owners will increase their confidence in vet businesses and the profession.”
Industry reactions
The announcement triggered immediate market reactions. Bloomberg reported Shares of CVS Group, a British veterinary services provider, rose as much as 18 per cent in early London trading before paring gains, whilst Pets at Home traded up to 4.9 per cent higher. Both companies had underperformed since the CMA launched its investigation.
“While the tone of the CMA’s report is sharp, we see few surprises versus our expectations,” said Jefferies analyst Andrew Wade to Bloomberg. “The lack of pricing controls on services notably medicines must be viewed as a positive.”
The veterinary profession offered cautious support for the reforms. Dr Rob Williams, president of the British Veterinary Association, said: “At first glance, there’s lots of positives in the CMA’s provisional decision that both vets and pet owners will welcome, including greater transparency of pricing and practice ownership."
However, animal welfare charities warned of the consequences when pet owners delay treatment due to cost concerns. Caroline Allen, the RSPCA’s Chief Veterinary Officer, told BBC “Our frontline officers sadly see first-hand the consequences when people delay or avoid seeking professional help, or even attempt to treat conditions themselves."
The proposed remedies package also includes requirements for vet businesses to improve complaint processes and conduct regular customer satisfaction surveys comparing large groups with independent practices. Additionally, practices would find it easier to terminate out-of-hours contracts with third-party providers if better alternatives exist.
The CMA emphasised that vet businesses failing to comply, or those pressuring veterinarians to act in certain ways or sell specific treatments, could be in breach of the Order.
By clicking the 'Subscribe’, you agree to receive our newsletter, marketing communications and industry
partners/sponsors sharing promotional product information via email and print communication from Garavi Gujarat
Publications Ltd and subsidiaries. You have the right to withdraw your consent at any time by clicking the
unsubscribe link in our emails. We will use your email address to personalize our communications and send you
relevant offers. Your data will be stored up to 30 days after unsubscribing.
Contact us at data@amg.biz to see how we manage and store your data.